MedPath

The effectiveness of reducing the incidence of preterm birth in IVF/ICSI twins using natural progesterone starting from the first trimester

Not Applicable
Completed
Conditions
Preterm labor and twins
Pregnancy and Childbirth
Registration Number
ISRCTN69810120
Lead Sponsor
The Egyptian IVF-ET Center (Egypt)
Brief Summary

2020 results in https://pubmed.ncbi.nlm.nih.gov/32517660/ (added 11/06/2020)

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Female
Target Recruitment
203
Inclusion Criteria

1. Healthy pregnant females in twins after IVF/ICSI with no previous history of preterm birth
2. Age > 18 years
3. Agree to be randomized at the time of the first trimester scan (12 weeks)

Exclusion Criteria

1. Smokers
2. Major known fetal anomalies
3. Uterine anomalies
4. Cervical cerclage
5. Monochorionic twins

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath